|
|
Eli Lilly And Company (LLY) |
|
|
|
Eli Lilly's Yearly Income from Continued Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
LLY Annual Income from Cont. Operations Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual Income from Cont. Operations Change |
-16.08 % |
11.88 % |
-9.88 % |
33.55 % |
43.5 % |
Annual Income from Cont. Operations (in millions $) |
$5,240.40 |
$6,244.80 |
$5,581.70 |
$6,193.70 |
$4,637.90 |
Annual Income from Cont. Operations Growth
Comment |
Eli Lilly And Company experienced detoriation of Annual Income from Cont. Operations for the fiscal year ended 2023 by -16.08% to $ 5,240.40 millions, compare to $ 6,244.80 in Annual Income from Cont. Operations reported in the previous year. The decline in company's annual Income from Continued Operations accelerated, from the 11.88 % gain, in the fiscal year ended 2022.
Eli Lilly Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Income from Cont. Operations within Healthcare Sector | Y/Y Income from Continued Operations Growth % | 2023 Annual Income from Cont. Operations | Pfizer Inc | -93.08 % | $ 2,173.000 millions | Johnson and Johnson | -25.72 % | $ 13,326.000 millions | Biontech Se | -90.14 % | $ 1,041.936 millions | Novartis Ag | 113.57 % | $ 14,854.000 millions | Biogen Inc | -60.78 % | $ 1,161.500 millions | Zoetis Inc | 10.85 % | $ 2,340.000 millions | Takeda Pharmaceutical Company Limited | 30.34 % | $ 2,196.436 millions | Becton Dickinson And Company | -6.42 % | $ 1,530.000 millions | Edwards Lifesciences Corporation | -8.05 % | $ 1,399.400 millions | Intuitive Surgical Inc | 35.18 % | $ 1,817.300 millions | Agilent Technologies inc | -1.12 % | $ 1,240.000 millions | Iqvia Holdings Inc | 24.47 % | $ 1,358.000 millions | Quest Diagnostics Inc | -10.54 % | $ 908.000 millions | Fresenius Medical Care Ag | -18.10 % | $ 820.353 millions | Tenet Healthcare Corp | 31.10 % | $ 1,311.000 millions | Organon and Co | 11.56 % | $ 1,023.000 millions | Mettler toledo International Inc | -9.60 % | $ 788.778 millions | Resmed Inc | 15.15 % | $ 897.556 millions | Davita Inc | 24.58 % | $ 956.978 millions | United Therapeutics Corporation | 35.40 % | $ 984.800 millions | Boston Scientific Corporation | 128.08 % | $ 1,592.000 millions | Idexx Laboratories Inc | 24.44 % | $ 845.042 millions | West Pharmaceutical Services Inc | 1.28 % | $ 593.400 millions | Vir Biotechnology Inc | | | |